Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Jan;8(1):40-5.
doi: 10.1038/sj.embor.7400873.

Peptidyl-prolyl cis/trans isomerases and transcription: is there a twist in the tail?

Affiliations
Review

Peptidyl-prolyl cis/trans isomerases and transcription: is there a twist in the tail?

Peter E Shaw. EMBO Rep. 2007 Jan.

Abstract

Eukaryotic transcription is regulated predominantly by the post-translational modification of the participating components. One such modification is the cis-trans isomerization of peptidyl-prolyl bonds, which results in a conformational change in the protein involved. Enzymes that carry out this reaction include the yeast peptidyl-prolyl cis/trans isomerase Ess1 and its human counterpart Pin1, both of which recognize phosphorylated target motifs exclusively. Consequently, they operate together with proline-directed serine-threonine kinases and phosphatases. High-profile client proteins involved in transcription include steroid hormone receptors, cell-cycle regulators and immune mediators. Other key targets are elements of the transcription machinery, including the multiply phosphorylated carboxy-terminal domain of RNA polymerase II. Changes in isomerase activity have been shown to alter the transactivation potential, protein stability or intracellular localization of these client proteins. The resulting disruption to developmental processes and cell proliferation has been linked, in some cases, to human cancers.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The peptidyl-prolyl isomerase Pin1/Ess1 acts in three ways in transcriptional activation. In the first scenario (blue), PPI activity protects client proteins such as β-catenin and p53 from proteasomal degradation, allowing them to participate in promoter binding and gene activation. In the second scenario (red), conformational change triggers ubiquitin-dependent degradation by the proteasome (grey box), which might (for example, in the case of retinoic-acid receptor α or steroid-receptor coactivator-3) or might not (for example, in the case of c-Myc or interferon-regulatory factor 3) be linked to transcriptional potency. The third scenario (turquoise) involves direct interaction of Pin1 with the carboxy-terminal domain of RNA polymerase II (RNAP II), which has been implicated in downregulation of the polymerase during mitosis, polymerase recycling and elongation. PPI, peptidyl-prolyl isomerase.
None
Peter E. Shaw

References

    1. Acquaviva C, Bossis G, Ferrara P, Brockly F, Jariel-Encontre I, Piechaczyk M (2002) Multiple degradation pathways for Fos family proteins. Ann NY Acad Sci 973: 426–434 - PubMed
    1. Adhikary S et al. (2005) The ubiquitin ligase HectH9 regulates transcriptional activation by Myc and is essential for tumor cell proliferation. Cell 123: 409–421 - PubMed
    1. Akoulitchev S, Chuikov S, Reinberg D (2000) TFIIH is negatively regulated by cdk8-containing mediator complexes. Nature 407: 102–106 - PubMed
    1. Allison LA, Wong JK, Fitzpatrick VD, Moyle M, Ingles CJ (1988) The C-terminal domain of the largest subunit of RNA polymerase II of Saccharomyces cerevisiae, Drosophila melanogaster, and mammals: a conserved structure with an essential function. Mol Cell Biol 8: 321–329 - PMC - PubMed
    1. Archambault J, Pan G, Dahmus GK, Cartier M, Marshall N, Zhang S, Dahmus ME, Greenblatt J (1998) FCP1, the RAP74-interacting subunit of a human protein phosphatase that dephosphorylates the carboxyl-terminal domain of RNA polymerase IIO. J Biol Chem 273: 27593–27601 - PubMed

Publication types

MeSH terms

LinkOut - more resources